Comparative Efficacy of Newer Antidepressants in Combination with Pregabalin for Fibromyalgia Syndrome: A Controlled, Randomized Study

Pain Practice

Volumn 17, Issue 1, 2017, Pages 32-40

  Ramzy, Eiad A ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

amitriptyline; depression; fibromyalgia; paroxetine; somatosensory disorder; tolerability; venlafaxine

Indexed keywords

AMITRIPTYLINE; PAROXETINE; PREGABALIN; VENLAFAXINE; ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; BLURRED VISION; BODY WEIGHT DISORDER; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENTEROPATHY; FATIGUE; FEMALE; FIBROMYALGIA; FOLLOW UP; HALLUCINATION; HEARTBURN; HUMAN; HYPERPHAGIA; HYPERTENSION; LIFE SATISFACTION; MAJOR CLINICAL STUDY; MICTURITION DISORDER; MOOD; MUSCULOSKELETAL DISEASE ASSESSMENT; PARKINSONISM; RANDOMIZED CONTROLLED TRIAL; SEROTONIN SYNDROME; SEXUAL DYSFUNCTION; SINGLE DRUG DOSE; SLEEP QUALITY; SOMATIC SYMPTOMS SCALE 8; TASTE DISORDER; XEROSTOMIA; COMBINATION DRUG THERAPY; DEPRESSION; MALE; MIDDLE AGED; PSYCHOLOGY; QUALITY OF LIFE;

ADULT; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS; DEPRESSION; DRUG THERAPY, COMBINATION; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; PAROXETINE; PREGABALIN; QUALITY OF LIFE; VENLAFAXINE HYDROCHLORIDE;

EID: 84975689864     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/papr.12409     Document Type: Article

References (29)

1. Coaccioli S, Varrassi G, Sabatini C, et al. Fibromyalgia: nosography and therapeutic perspectives. Pain Pract. 2008;8:190–201.
2. Guymer E, Littlejohn G. Fibromylagia. Aust Fam Physician. 2013;42:690–694.
3. Wolfe F, Clauw DJ, Fitzcharles MA, et al. American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010;62:600–610.
4. Peñacoba Puente C, Velasco Furlong L, Ecija Gallardo C, Cigarán Méndez M, McKenney K. Anxiety, depression and alexithymia in fibromyalgia: are there any differences according to age? J Women Aging. 2013;25:305–320.
5. Sommer C, Häuser W, Burgmer M, et al. Etiology and pathophysiology of fibromyalgia syndrome. Schmerz. 2012;26:259–267.
6. Carville SF, Arendt-Nielsen S, Bliddal H, et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis. 2008;67:536–541.
7. Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2012;12:CD008242.
8. Carta M, Ruggiero V, Sancassiani F, et al. The use of antidepressants in the long-term treatment should not improve the impact of fibromyalgia on quality of life. Clin Pract Epidemiol Ment Health. 2013;9:120–124.
9. Häuser W, Urrútia G, Tort S, Uçeyler N, Walitt B. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome. Cochrane Database Syst Rev. 2013;1:CD010292.
10. Angeletti C, Guetti C, Piroli A, et al. Duloxetine and pregabalin for pain management in multiple rheumatic diseases associated with fibromyalgia. Pain Pract. 2013;13:657–662.
11. Kim SC, Landon JE, Solomon DH. Clinical characteristics and medication uses among fibromyalgia patients newly prescribed amitriptyline, duloxetine, gabapentin or pregabalin. Arthritis Care Res (Hoboken). 2013;28:33–45.
12. Andrisano C, Chiesa A, Serretti A. Newer antidepressants and panic disorder: a meta-analysis. Int Clin Psychopharmacol. 2013;28:33–45.
13. Thaler KJ, Morgan LC, Van Noord M, et al. Comparative effectiveness of second-generation antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review. Depress Anxiety. 2012;29:495–505.
14. Gierk B, Kohlmann S, Kroenke K, et al. The somatic symptom scale-8 (SSS-8): a brief measure of somatic symptom burden. JAMA Intern Med. 2014;174:399–407.
15. Littlejohn GO, Guymer EK. Fibromyalgia syndrome: which antidepressant drug should we choose. Curr Pharm Des. 2006;12:3–9.
16. Calandre EP, Rico-Villademoros F, Slim M. An update on pharmacotherapy for the treatment of fibromyalgia. Expert Opin Pharmacother. 2015;16:1347–1368.
17. Theadom A, Cropley M, Smith HE, Feigin VL, McPherson K. Mind and body therapy for fibromyalgia. Cochrane Database Syst Rev. 2015;4:CD001980.
18. Ravindran AV, Cameron C, Bhatla R, Ravindran LN, da Silva TL. Paroxetine in the treatment of dysthymic disorder without co-morbidities: a double-blind, placebo-controlled, flexible-dose study. Asian J Psychiatr. 2013;6:157–161.
19. Patkar AA, Masand PS, Krulewicz S, et al. A randomized, controlled, trial of controlled release paroxetine in fibromyalgia. Am J Med. 2007;120:448–454.
20. Giordano N, Geraci S, Santacroce C, Mattii G, Battisti E, Gennari C. Efficacy and tolerability of paroxetine in patients with fibromyalgia syndrome: a single-blind study. Cur Therap Res. 1999;60:696–702.
21. Bernik M, Sampaio TP, Gandarela L. Fibromyalgia comorbid with anxiety disorders and depression: combined medicaland psychological treatment. Curr Pain Headache Rep. 2013;17:358.
22. Arnold LM, Hess EV, Hudson JI, Welge JA, Berno SE, Keck PE Jr. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med. 2002;15:191–197.
23. Handley AP, Williams M. The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review. J Am Assoc Nurse Pract. 2014;27:54–61.
24. Stokes PE. Fluoxetine: a five years review. Clin Ther. 1993;15:216–243.
25. Sayar K, Aksu G, Ak I, Tosun M. Venlafaxine treatment of fibromyalgia. Ann Pharmacother. 2003;37:1561–1565.
26. Dwight MM, Arnold LM, O'Brien H, Metzger R, Morris-Park E, Keck PE Jr. An open clinical trial of venlafaxine treatment of fibromyalgia. Psychosomatics. 1998;39:14–17.
27. Vander Weide LA, Smith SM, Trinkley KE. A systematic review of the efficacy of venlafaxine for the treatment of fibromyalgia. J Clin Pharm Ther. 2015;40:1–6.
28. Segura-Jiménez V, Aparicio VA, Álvarez-Gallardo IC, et al. Validation of the modified 2010 American College of Rheumatologydiagnostic criteria for fibromyalgia in a Spanish population. Rheumatology (Oxford). 2014;53:1803–1811.
29. Wang SM, Han C, Lee SJ, et al. Fibromyalgia diagnosis: a review of the past, present and future. Expert Rev Neurother. 2015;15:667–679.